Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer

Androgen deprivation therapy is the mainstay of treatment of advanced prostate cancer (PCa). However, a significant portion of patients experience disease relapse and tumors ultimately evolve into castration resistant prostate cancer (CRPC), for which there is no cure in the clinic. The Polycomb pro...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Wu, Changping, Jin, Xin, Yang, Jing, Yang, Yinhui, He, Yundong, Ding, Liya, Pan, Yunqian, Chen, Shuai, Jiang, Jingting, Huang, Haojie
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2015
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4823118/
https://ncbi.nlm.nih.gov/pubmed/26657505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6497
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍